Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma

被引：0
|
作者：
Kazuma Sugimoto
Satoru Taguchi
Kenjiro Kishitani
Taketo Kawai
Kazuki Masuda
Yu Nakamura
Manami Kinjo
Mitsuhiro Tambo
Jimpei Miyakawa
Yoshiyuki Akiyama
Yuta Yamada
Yusuke Sato
Daisuke Yamada
Tohru Nakagawa
Hiroshi Fukuhara
Haruki Kume
机构：
[1] Kyorin University School of Medicine,Department of Urology
[2] The University of Tokyo,Department of Urology, Graduate School of Medicine
[3] Teikyo University School of Medicine,Department of Urology
来源：
BMC Urology | / 22卷
关键词：
Advanced; Carboplatin; Cisplatin; Metastatic; Renal function; Urothelial carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma
    Sugimoto, Kazuma
    Taguchi, Satoru
    Kishitani, Kenjiro
    Kawai, Taketo
    Masuda, Kazuki
    Nakamura, Yu
    Kinjo, Manami
    Tambo, Mitsuhiro
    Miyakawa, Jimpei
    Akiyama, Yoshiyuki
    Yamada, Yuta
    Sato, Yusuke
    Yamada, Daisuke
    Nakagawa, Tohru
    Fukuhara, Hiroshi
    Kume, Haruki
    BMC UROLOGY, 2022, 22 (01)
  • [2] Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma
    Miyake, Makito
    Shimizu, Takuto
    Nishimura, Nobutaka
    Kiba, Keisuke
    Maesaka, Fumisato
    Oda, Yuki
    Tachibana, Akira
    Tomizawa, Mitsuru
    Ohmori, Chihiro
    Matsumura, Yoshiaki
    Ichikawa, Kazuki
    Mizobuchi, Shinichiro
    Yoshikawa, Takanosuke
    Hori, Shunta
    Morizawa, Yosuke
    Gotoh, Daisuke
    Nakai, Yasushi
    Anai, Satoshi
    Torimoto, Kazumasa
    Aoki, Katsuya
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    CLINICAL GENITOURINARY CANCER, 2022, 20 (02) : 196.e1 - 196.e9
  • [3] Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma
    Yi Rang Kim
    Jae Lyun Lee
    Dalsan You
    In Gab Jeong
    Cheryn Song
    Bumsik Hong
    Jun Hyuk Hong
    Hanjong Ahn
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 141 - 153
  • [4] Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma
    Kim, Yi Rang
    Lee, Jae Lyun
    You, Dalsan
    Jeong, In Gab
    Song, Cheryn
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 141 - 153
  • [5] Tislelizumab plus cisplatin/carboplatin and gemcitabine versus placebo plus cisplatin/carboplatin and gemcitabine in Chinese patients with advanced urothelial carcinoma: A phase III trial in progress
    Bi, Feng
    Li, Han-Zhong
    Zhu, Shaoxing
    Zou, Qing
    Tang, Jia
    Zhang, Wei
    Ye, Dingwei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [6] Quality of life during gemcitabine plus cisplatin or gemcitabine plus carboplatin for urothelial carcinoma
    Hatakeyama, S.
    Yoneyama, T.
    Hashimoto, Y.
    Koie, T.
    Ohyama, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [7] Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer
    S P Hong
    J Y Park
    T J Jeon
    S Bang
    S W Park
    J B Chung
    M-S Park
    J Seong
    W J Lee
    S Y Song
    British Journal of Cancer, 2008, 98 : 881 - 887
  • [8] Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer
    Hong, S. P.
    Park, J. Y.
    Jeon, T. J.
    Bang, S.
    Park, S. W.
    Chung, J. B.
    Park, M-S
    Seong, J.
    Lee, W. J.
    Song, S. Y.
    BRITISH JOURNAL OF CANCER, 2008, 98 (05) : 881 - 887
  • [9] Gemcitabine Plus Cisplatin Split Versus Gemcitabine Plus Carboplatin for Advanced Urothelial Cancer With Cisplatin-unfit Renal Function
    Izumi, Kouji
    Iwamoto, Hiroaki
    Yaegashi, Hiroshi
    Shigehara, Kazuyoshi
    Nohara, Takahiro
    Kadono, Yoshifumi
    Mizokami, Atsushi
    IN VIVO, 2019, 33 (01): : 167 - 172
  • [10] Timing of changing therapy from gemcitabine and cisplatin chemotherapy based on real-world data of advanced urothelial carcinoma
    Furubayashi, Nobuki
    Negishi, Takahito
    Takamatsu, Dai
    Ieiri, Kosuke
    Inoue, Tomohiro
    Tsukino, Keiji
    Nakamura, Motonobu
    ONCOLOGY LETTERS, 2020, 19 (04) : 2943 - 2949
12345